NUCKS1
Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1
Also known as: NUCKS, NUCKS_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H1E3
- Gene
- NUCKS1
- Ensembl
- ENSG00000069275
- Chromosome
- 1
- Canonical length
- 243 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a nuclear protein that is highly conserved in vertebrates. The conserved regions of the protein contain several consensus phosphorylation sites for casein kinase II and cyclin-dependent kinases, two putative nuclear localization signals, and a basic DNA-binding domain. It is phosphorylated in vivo by Cdk1 during mitosis of the cell cycle. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
243 residues, UniProt reviewed canonical sequence.
>Q9H1E3|NUCKS1
1 MSRPVRNRKV VDYSQFQESD DADEDYGRDS GPPTKKIRSS PREAKNKRRS GKNSQEDSED
61 SEDKDVKTKK DDSHSAEDSE DEKEDHKNVR QQRQAASKAA SKQREMLMED VGSEEEQEEE
121 DEAPFQEKDS GSDEDFLMED DDDSDYGSSK KKNKKMVKKS KPERKEKKMP KPRLKATVTP
181 SPVKGKGKVG RPTASKASKE KTPSPKEEDE EPESPPEKKT STSPPPEKSG DEGSEDEAPS
241 GEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NUCKS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.71
- Highest tissue expression
- 107 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 107 nTPM
- cerebral cortex: 102 nTPM
- liver: 97 nTPM
- ovary: 97 nTPM
- tongue: 95 nTPM
- spinal cord: 94 nTPM
Single-cell type
- megakaryocyte progenitors: 784 nCPM
- hepatocytes: 768 nCPM
- monocyte progenitors: 650 nCPM
- erythrocyte progenitors: 552 nCPM
- megakaryocytes: 538 nCPM
- smooth muscle cells: 514 nCPM
Immune cell
- NK-cell: 11 nTPM
- naive CD8 T-cell: 11 nTPM
- naive CD4 T-cell: 10 nTPM
- gdT-cell: 9.1 nTPM
- MAIT T-cell: 8.8 nTPM
- memory CD4 T-cell: 8.3 nTPM
Brain region
- white matter: 203 nTPM
- basal ganglia: 169 nTPM
- spinal cord: 168 nTPM
- medulla oblongata: 166 nTPM
- hypothalamus: 155 nTPM
- thalamus: 155 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.09
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to X-ray
- chromatin organization
- double-strand break repair via homologous recombination
- host-mediated activation of viral genome replication
- host-mediated activation of viral transcription
- host-mediated perturbation of viral genome replication
- interstrand cross-link repair
- intracellular glucose homeostasis
- positive regulation of insulin receptor signaling pathway
- positive regulation of transcription by RNA polymerase II
- regulation of DNA replication
- regulation of DNA strand elongation
- regulation of insulin receptor signaling pathway
- replication fork processing
- gene conversion
Molecular functions
- chromatin binding
- DNA-binding transcription factor binding
- double-stranded DNA binding
- RNA binding
- single-stranded DNA binding
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NUCKS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NUCKS1 as an antibody target. Whether an autoantibody or antibody against NUCKS1 could matter depends on whether native NUCKS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NUCKS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NUCKS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...